Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Erstveröffentlichung
2016Authors
Wallentin, Lars
Held, Claes
Armstrong, Paul W.
Cannon, Christopher P.
Davies, Richard Y.
Wissenschaftlicher Artikel
Published in
Journal of the American Heart Association ; 5 (2016), 6. - Art.-Nr. e003407. - ISSN 2047-9980